Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ajt.16636 http://scihub22266oqcxt.onion/10.1111/ajt.16636 33961334!8222938!33961334     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33961334&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Am+J+Transplant 2021 ; 21 (8): 2871-2875 Nephropedia Template TP {{tp|p=33961334|t=2021. Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19 |pdf=|usr=}}{{33961334}} gab.com Text Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19 JO: Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=33961334 #FOAvip The exact duration of viable SARS-CoV-2 shedding in kidney transplant recipients (KTRs) remains unclear. Here, we retrospectively investigated this issue using cell cultures of SARS-CoV-2 RT-PCR-positive nasopharyngeal samples (n = 40) obtained from 16 KTRs with symptomatic COVID-19 up to 39 days from symptom onset. A length of viable SARS-CoV-2 shedding >3 weeks from the onset of symptoms was identified in four KTRs (25%). These results suggest that a significant proportion of KTRs can shed viable SARS-CoV-2 for at least 3 weeks, which may favor the emergence of new variants. Based on these data, we recommend prolonging the isolation of KTRs with COVID-19 until negative SARS-CoV-2 RT-PCR testing. Twit Text FOAVip Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19 ????Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=33961334 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33961334 #FOAvip English Wikipedia <ref>{{Cite pmid|33961334}}</ref> Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19 #MMPMID33961334 Benotmane I; Risch S; Doderer-Lang C; Caillard S; Fafi-Kremer S Am J Transplant 2021[Aug]; 21 (8): 2871-2875 PMID33961334show ga The exact duration of viable SARS-CoV-2 shedding in kidney transplant recipients (KTRs) remains unclear. Here, we retrospectively investigated this issue using cell cultures of SARS-CoV-2 RT-PCR-positive nasopharyngeal samples (n = 40) obtained from 16 KTRs with symptomatic COVID-19 up to 39 days from symptom onset. A length of viable SARS-CoV-2 shedding >3 weeks from the onset of symptoms was identified in four KTRs (25%). These results suggest that a significant proportion of KTRs can shed viable SARS-CoV-2 for at least 3 weeks, which may favor the emergence of new variants. Based on these data, we recommend prolonging the isolation of KTRs with COVID-19 until negative SARS-CoV-2 RT-PCR testing. |*COVID-19[MESH] |*Kidney Transplantation/adverse effects[MESH] |Humans[MESH] |Nasopharynx[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH]Long-term shedding of viable SARS-CoV-2 in kidney transplant recipient(epmc).pdf DeepDyve Pubget Overpricing